Chronic kidney disease growth factors in renal fibrosis

Area of Science:

• Nephrology
• Molecular Biology
• Biochemistry

Background:

• Renal fibrosis is a common pathological feature in progressive chronic kidney disease (CKD).
• Growth factors play a critical role in the development and progression of renal fibrosis.
• Understanding the specific roles of various growth factors is crucial for developing effective therapeutic strategies.

Purpose of the Study:

• To review the established and emerging roles of growth factors in renal fibrosis.
• To explore the potential of growth factors as biomarkers for CKD.
• To discuss the therapeutic implications of targeting growth factors in renal fibrosis.

Main Methods:

• Literature review focusing on growth factors implicated in renal fibrosis.
• Analysis of the roles of transforming growth factor-β (TGF-β), connective tissue growth factor (CTGF), bone morphogenic protein 7 (BMP-7), platelet-derived growth factor (PDGF), and vascular endothelial growth factor (VEGF).
• Examination of preclinical and clinical data regarding growth factor manipulation for CKD treatment.

Main Results:

• Transforming growth factor-β and CTGF are key profibrotic factors, while BMP-7 exhibits antifibrotic properties.
• The roles of PDGF and VEGF in renal fibrosis are still under investigation.
• Growth factors present potential as circulating or excreted biomarkers for renal fibrosis and CKD.
• Animal studies indicate that modulating growth factors could be a viable treatment for renal fibrosis.

Conclusions:

• Growth factors are central to the pathogenesis of renal fibrosis in CKD.
• Targeting specific growth factors, such as CTGF, offers a promising therapeutic avenue.
• Further research is needed to fully elucidate the roles of all relevant growth factors and their potential as biomarkers and therapeutic targets in CKD.